India is struggling at 244 for 7, trailing by 230 runs against Australia's 474. They need 111 more to avoid the follow-on, with Pant and Jadeja at the crease. If India scores below 275, Australia ...

NEW DELHI, Dec 26 (Reuters) - India is considering cutting income tax for individuals making up to 1.5 million rupees ($17,590) a year in February's budget to provide relief to the middle class ...

The companies were allowed to market a generic version of Liraglutide for the treatment of Type-2 diabetes and for weight management. These treatments are essentially generic versions of the ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

commonly found in viagra, said FDCA commissioner HG Koshia. The FDCA's investigation revealed the practice of mixing sildenafil citrate with purported nutraceuticals, called ‘Wholeshield Refire ...

Over 14,000 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been opened in the country as on October 21 to provide quality generic medicines at affordable prices, Union Health Minister J P ...

In a pursuit to make quality healthcare more affordable, India has opened over 14,000 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) as of October 21. These outlets provide generic medicines at ...

India's agreement with Iran in May to manage the strategic Chabahar Port for the next decade marked a significant milestone, as it was the first time India assumed management of a port overseas and ...

India's cricketing icon Virat Kohli, who has often been a subject of debate on social media over spending a lot of time in the United Kingdom, is reportedly set to shift base soon. According to ...

MUMBAI, Dec 19 (Reuters Breakingviews) - There are some startling similarities developing between India and China. How many and how concerned investors should be will rank among the big questions ...

Drug maker Granules India Ltd. announced on Tuesday that its subsidiary, Granules Pharmaceuticals Inc., has received approval from the US Food and Drug Administration for a generic version ... the ...

affordable medications," Granules Ltd Chairman & Managing Director Krishna Prasad Chigurupati said. Shares of Granules India were trading 0.74 per cent up at Rs 588.65 apiece on BSE.